Register
Login:
Share:
Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'


Regulatory News


Grant of Options & Director/PDMR Shareholdings

Fri, 10th Nov 2017 07:00


RNS Number : 1075W
Byotrol PLC
10 November 2017

10 November 2017

Byotrol plc

GRANT OF OPTIONS

DIRECTOR SHAREHOLDINGS

The Board of Byotrol plc ('Byotrol' or the 'Company'), thespecialistanti-microbialtechnologycompany, announces that on 9 November 2017, it granted a total of 10,296,750 options over the Company's ordinary shares of 0.25 pence each ("Options" and "Ordinary Shares" respectively) representing 2.56 per cent. of the issued share capital of the Company to two Directors and certain employees of the Company, upon the recommendation of the Company's Remuneration Committee.

Details of the awards to the two Directors and a PDMR of the Company are set out below (the "Director/PDMR Options"):

Position

No. of New Options Granted

No. of Options held post Grant

Shareholding in Company

Percentage of fully diluted share capital

David Traynor

Chief Executive

1,000,000

6,900,000

4,850,514

2.92%

Dr Trevor Francis

Chief Technology Officer

2,375,000

6,325,000

2,253,216

2.13%

Denise Keenan

Head of Finance (PDMR)

1,792,500

3,217,500

-

0.80%

TOTAL

5,167,500

5.85%

The above Director/PDMR Options, which are exercisable at 4 pence per Ordinary Share over a seven year period, vest on the following basis;

-30% vest after 12 months if the mid - share price averages over 5p for a 30 day period

35% vest after 24 months if the mid - share price averages over 7.5p for a 30 day period

35% vest after 36 months if the mid - share price averages over 10p for a 30 day period

The 5,167,500 Director/PDMR Options are being granted under the Company's Enterprise Management Incentive Scheme.

The remaining 5,129,250 Options are being awarded to a number of key employees of the Company ("Employee Options"). These Employee Options are also exercisable at 4 pence per Ordinary Share between 9 November 2018 and expire in tranches up to 9 May 2025. All 10,296,750 Options granted today will vest on any change of control of the Company.

Following the grant of the 10,296,750 Options, there will be 35,244,250 Options in issue representing 8.75% per cent. of the Company's issued share capital.

Enquiries:

Byotrol plc

01925 742 000

John Langlands - Chairman

David Traynor - Chief Executive

finnCap Ltd

020 7220 0500

Geoff Nash / Carl Holmes / James Thompson- Corporate Finance

Stephen Norcross / Richard Chambers - Corporate Broking

Notes to Editors:

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of residual antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.

Our patented suite of technologies deliver powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens.

Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.

For more information, please go to www.byotrol.co.uk

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Traynor

2.

Reason for the Notification

a)

Position/status

Chief Executive

b)

Initial notification/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

options over ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Award of Options to subscribe for Ordinary Shares

c)

Price(s) and volume(s)

Volume - 1,000,000

Exercise Price - 4 pence

d)

Aggregated information:

See 4c) above

e)

Date of the transaction

9 November 2017

f)

Place of the transaction

Outside of a trading venue

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Trevor Francis

2.

Reason for the Notification

a)

Position/status

Chief Technology Officer

b)

Initial notification/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

options over ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Award of Options to subscribe for Ordinary Shares

c)

Price(s) and volume(s)

Volume - 2,375,000

Exercise Price - 4 pence

d)

Aggregated information:

See 4c) above

e)

Date of the transaction

9 November 2017

f)

Place of the transaction

Outside of a trading venue

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Denise Keenan

2.

Reason for the Notification

a)

Position/status

Head of Finance and Company Secretary (PDMR)

b)

Initial notification/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Byotrol Plc

b)

LEI

213800AJMTSTIPA59A34

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

options over ordinary shares of 0.25p each

Identification code

GB00B0999995

b)

Nature of the transaction

Award of Options to subscribe for Ordinary Shares

c)

Price(s) and volume(s)

Volume - 1,792,500

Exercise Price - 4 pence

d)

Aggregated information:

See 4c) above

e)

Date of the transaction

9 November 2017

f)

Place of the transaction

Outside of a trading venue


This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDMMGMNLGGNZM


Related Shares:
Byotrol (BYOT)



Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.